Skip to main content
. 2022 Feb 10;2022:8733598. doi: 10.1155/2022/8733598

Table 1.

Baseline demographic data.

Variable Treatment group
N = 72
Control group
N = 72
P value
Age (y, x ± s) 49.56 ± 14.88 52.81 ± 14.83 0.1915
Males (N, %) 23 (31.94%) 24 (33.33%) 0.8589
Temperature (°C, x ± s) 37.14 ± 0.81 37.01 ± 0.83 0.2164
Respiratory rate (bpm, x ± s) 19.75 ± 2.45 19.60 ± 2.15 0.6329
Pulse (times/min, x ± s) 79.72 ± 10.21 76.90 ± 9.02 0.3402
Systolic pressure (mmHg, x ± s) 124.75 ± 16.30 127.61 ± 13.14 0.0847
Diastolic pressure (mmHg, x ± s) 79.88 ± 9.51 80.53 ± 10.29 0.3990
Routine blood test
 Leukocyte count (N, x ± s) 5.09 ± 1.79 5.18 ± 1.50 0.5323
 Neutrophil percentage (%, x ± s) 60.94 ± 12.46 61.22 ± 13.26 0.7064
 Lymphocyte count (N, x ± s) 1.49 ± 0.60 1.49 ± 0.51 0.5987
 Concomitant medications 56 (78.87%) 65 (90.28%) 0.0588

P value, comparison between the treatment group and the control group. P < 0.05 indicates a significant difference.